IBT Wujiang Technology Appears at CMEF: Driven by Artificial Intelligence and Big Data Dual Engines, Wisdom Leads the Future of Wujiang

From May 14th to 17th, the 87th China International Medical Equipment Fair (CMEF), known as the "aircraft carrier-level event of the global medical industry", was held grandly at the Shanghai National Convention and Exhibition Center. IBT Wujiang Technology, a brain science smart medical company focusing on children and adolescents' mental health services, brings digital medical products "Zhuanjingtong Attention Deficit Hyperactivity Disorder (ADHD) and Focus Multi-dimensional Digital Solution" and "Wujiang Knowledge for Children Aged 3-6" "Cognitive Function Assessment and Intervention System" and "AtMind Guanxin Cloud Intelligent Mental and Psychological Service Platform" were unveiled at CMEF.

According to data from the National Bureau of Statistics, in the first quarter of 2023, the total revenue of China's medical device industry was 236.83 billion yuan, a year-on-year increase of 18.7%. According to statistics from the Medical Device Association, the total size of China's medical device market reached 222 billion yuan in the first quarter of 2023, a year-on-year increase of 23.9%. As a benchmark for the medical device industry in the context of a comprehensive recovery of the economic situation, this year’s CMEF, with the theme of “Innovative Technology, Smart Future”, is based in China and looks at the world, attracting investors including GE Healthcare, Siemens Healthineers, Philips Healthcare, Mindray, and Yuyue Nearly 5,000 companies, including leading companies in the industry, more than a thousand industry experts and more than 200,000 viewers from 120 countries around the world participated in the grand event.

The exhibits at this year’s CMEF include cutting-edge products for many popular track segments. As a brain science smart medical company focusing on children and adolescents' mental health services, IBT Wujiang Technology publicly demonstrated its digital medical product "Zhuanjingtong Attention Deficit Hyperactivity Disorder (ADHD) and Focus Multi-dimensional Digital Solution" at the CMEF exhibition for the first time. "Wujiangyoushi Cognitive Function Assessment and Intervention System for Children Aged 3-6" and "AtMind Guanxin Cloud Intelligent Mental and Psychological Service Platform" have attracted many investors, chief doctors of relevant departments of hospitals at all levels, and distributors. Stakeholders from both inside and outside the industry come to discuss cooperation and resource docking.

It is understood that the "Zhuanjingtong Multi-dimensional Digital Solution for Attention Deficit Hyperactivity Disorder (ADHD) and Concentration" that has received the most inquiries is a multi-dimensional digital solution for children aged 6-12 years old with attention deficit hyperactivity disorder (ADHD). The dimensional solution includes three parts: objective evaluation, digital training and ADHD family support system. According to reports, this objective evaluation relies on the technology of the State Key Laboratory of Cognitive Neuroscience and Learning of Beijing Normal University, and is modeled through hundreds of thousands of Chinese standard children's data, in terms of attention, self-control, memory, thinking, reaction, etc. In many aspects, in the form of interesting games, it conducts accurate assessments and generates comprehensive reports for children, including children with ADHD; digital training is based on the theory of brain functional partitioning, brain nerve remodeling theory and learning-neural activation theory, and is developed by " Driven by the dual engines of "artificial intelligence + big data", it matches the child's specific performance in completing the training tasks with the multi-level cognitive training map to recommend the most suitable intervention plan. IBT Wujiang Technology also set up an evaluation and experience session at the CMEF exhibition, and there was an endless stream of people coming to experience it.

Another exhibiting product of IBT Wujiang Technology, "Wujiang Youshi Cognitive Function Assessment and Intervention System for Children Aged 3-6" is a hospital-oriented product jointly developed and designed by in-depth cooperation with the Capital Institute of Pediatrics and Chongqing Maternal and Child Health Hospital. The Department of Child Care and Maternal and Child Health Hospital provide a digital system for cognitive function assessment and intervention for children aged 3 to 6 years old. According to reports, the system selects representative assessment paradigms for the key cognitive abilities of brain development in children aged 3 to 6 years old; the difficulty of the test can be differentiated according to the child's developmental age; the hospital only needs an electronic tablet device to carry out the test The test is administered without the need for medical staff to participate in the entire process - greatly reducing the cost of administering the test and being tested.

In addition, IBT Wujiang Technology has also launched a SaaS platform - AtMind Guanxin Cloud Intelligent Mental and Psychological Service Platform, which involves multi-disease psychological screening, digital therapy cognitive intervention, institutional dynamic collaborative management, in-hospital smart assessment clinical workstations, and health science popularization The eight systems of brand building interconnection, health risk big data early warning, scientific research data management, and family intelligent follow-up management provide full-scale platform support and guarantee for the medical system inside and outside the hospital.

Digitization is the only way for China's medical device industry to move from "quantity" to "quality and quality". IBT Wujiang Technology, a brain science smart medical company, is committed to providing accessible digital full-course solutions for mental and psychological diseases in children and adolescents. Driven by the twin engines of "artificial intelligence + big data", it is the epitome of "innovating technology and leading the future with wisdom" in the new year of "both quality and quality" of China's medical devices.